Disseminated intravascular coagulation
Also known as: DIC, Disseminated intravascular coagulopathy, Consumption coagulopathy
Disseminated intravascular coagulation (DIC) is a critical systemic syndrome characterised by pathological, widespread activation of coagulation. This results in disseminated microvascular thrombi which consume platelets and coagulation factors, leading to a paradoxical haemorrhagic diathesis and multi-organ dysfunction. Suspected DIC is a medical emergency necessitating immediate hospitalisation for intensive haemodynamic support and management of the primary aetiology. Acupuncture and Chinese herbal medicine are contraindicated in the acute phase. Traditional Chinese Medicine (TCM) support is only considered once the patient is stabilised and explicit clearance is granted by the primary medical team. Cited research provides no evidence for acupuncture in DIC management. A single case report involving herbal medicine is insufficient to establish efficacy; its computational findings serve only as a basis for further investigation. Recovery-phase patterns mentioned herein reflect traditional frameworks and are not validated treatments for DIC.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Prioritise all scheduled haematology consultations, follow-up appointments, and pathology investigations.
- •Maintain a comprehensive record of all pharmaceuticals and supplements; do not discontinue prescribed anticoagulants or initiate new herbal products without specialist medical consultation.
- •Adhere strictly to the hospital discharge nutritional and fluid management plan, particularly if renal, hepatic, or cardiac injury has occurred.
- •Incrementally increase physical activity according to the rehabilitation protocol, ensuring precautions are taken to avoid falls or contact injuries while coagulopathy risk is monitored.
Cautions & Contraindications
- •Do not perform acupuncture, bloodletting, wet cupping or vigorous scraping during suspected or active DIC, active bleeding or unresolved coagulopathy. This is a precaution based on the bleeding and critical-illness risks described in the supplied records, not a tested acupuncture finding.[,]
- •Defer elective TCM procedures and herbal prescribing during haemodynamic instability, ongoing severe infection or acute organ failure; prioritise multidisciplinary hospital care.[,]
- •Do not independently alter anticoagulation or use herbs to counteract its effects. The supplied ECMO/CRRT evidence supports specialist monitoring of bleeding and platelet changes, not a DIC treatment recommendation for TCM; pharmacovigilance signals do not establish causation.[]
- •Do not extrapolate the single leptospirosis herbal case report to the recovery formulas listed here or to acute DIC treatment. Concurrent conventional therapy and the uncontrolled design prevent attribution of benefit; computational predictions are not clinical efficacy evidence.[]
When to reassess or seek care again
Acute suspicion requires immediate emergency transfer, not a scheduled TCM reassessment. After complete medical stabilisation and explicit clearance, document baseline fatigue on a 0–10 scale, appetite, oral intake, dry-mouth burden and functional tolerance; review within 1–2 weeks. Laboratory monitoring and procedural clearance remain with the treating team. Stop adjunctive interventions and seek prompt medical review for deterioration or new bruising; bleeding, shock or organ-failure features require emergency escalation. Refer persistent or worsening recovery symptoms back to the treating team rather than escalating TCM treatment.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Frontiers in medicine · 2026
- Frontiers in pharmacology · 2026
- Frontiers in medicine · 2026
- Frontiers in medicine · 2026
- Cochrane Database of Systematic Reviews · 2015
Systematic review supporting PC6 stimulation for postoperative nausea and vomiting.
- JAMA Surgery · 2023
Randomised trial including ST36 for postoperative gastrointestinal recovery.
- World Health Organization · 2008
Standard point locations used for the adjunctive points listed.
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
